George I. Papakostas, MD

Original Research

Augmentation of Antidepressants With Atypical Antipsychotic Medications for Treatment-Resistant Major Depressive Disorder: A Meta-Analysis

June 15, 2007

Original Research

A Cross-Sectional Study of the Prevalence of Cognitive and Physical Symptoms During Long-Term Antidepressant Treatment

November 15, 2006

Article

Consensus Statement and Research Needs: The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment

June 15, 2006

Article

Symptoms of Fatigue and Sleepiness in Major Depressive Disorder

June 15, 2006

Original Research

Serum Prolactin Levels Among Outpatients With Major Depressive Disorder During the Acute Phase of Treatment With Fluoxetine

June 15, 2006

Article

Treatment-Resistant Depression

June 15, 2006

Original Research

Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder

October 14, 2005

Original Research

An Open Study of Triiodothyronine Augmentation of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Major Depressive Disorder

August 15, 2005

Original Research

Effects of Psychiatric Disorders and Psychotropic Medications on Prolactin and Bone Metabolism.

December 15, 2004

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

August 16, 2004

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

August 16, 2004

Original Research

Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in Major Depressive Disorder

April 1, 2004